Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
ROCSTAR
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2033
April 11, 2025
April 1, 2025
2.5 years
April 2, 2022
April 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of postoperative hospital stay
Length of postoperative hospital stay
hours from the end of surgery (last skin suture) until discharge, assessed up to 20 days
Secondary Outcomes (12)
Skin-to-skin operative time
Per-operative (minutes)
Conversion rate
Per-operative
Surgical site related complications
30 days
Readmission rate
30 Days and 3 months postoperative
Post-anesthetic discharge scoring system
From the end of surgery (last skin suture) until discharge, assessed up to 20 days
- +7 more secondary outcomes
Study Arms (2)
rTAR
ACTIVE COMPARATORPatients randomized in the robotic group will undergo the technique for intra-and perioperative management for robotic complex abdominal wall repair cases as used in the center. A robotic surgical platform (da Vinci X or da Vinci Xi Surgical System, Intuitive Surgical, Aubonne, Switzerland) will be used and a retrorectus +/- retromuscular mesh placement performed. Use of component separation or not will be at the discretion of the surgeon. In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique. Drain management and mesh fixation are left to the surgeon's preference.
oTAR
ACTIVE COMPARATORPatients randomized in the open group will undergo the technique for intra-and perioperative management for open complex abdominal wall repair cases as used in the center. A retrorectus +/- retromuscular mesh placement performed. Use of component separation or not will be at the discretion of the surgeon. In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique. Drain management and mesh fixation are left to the surgeon's preference.
Interventions
Incisional hernia repair for the treatment of wide ventral incisional hernias.
Eligibility Criteria
You may qualify if:
- \- All patients requiring treatment of a wide ventral incisional hernia (of more than 8 centimetres in width)
You may not qualify if:
- Pregnant or suspected pregnancy
- Not-curatively treated malignancy, with life expectancy less than 24 months
- Patients unable to give informed consent or complete study specific questionnaires
- Emergency surgery
- Primary ventral hernia repair
- Exclusively lateral hernias not involving the midline
- Incisional hernia repair after open abdomen or enterocutaneous fistula
- Active wound infection
- Previous anterior or posterior component separation
- Patients with an existing ostomy
- Patients with a life expectancy of less than 24 months
- Patients suspected of being unable to comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filip Muysoms, MD PhD
Clinical research center Maria Middelares
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label Randomized Controlled Trial (RCT) where the patient, surgeon, research coordinators and hospital staff will be aware of the treatment arm after randomization. As the open approach is performed using a large midline incision, whereas the robotic approach applies only 6 or 7 small incisions (or less if no posterior component separation is needed), blinding of patients and physicians is difficult. Evaluation of the radiographic imaging of the abdominal wall at 24 months (MRI or CT scan) will be done by radiologists at the local participating center blinded to the randomized treatment arm. This will be a blinded evaluation for the presence or absence of hernia recurrence. Data analysis will be performed in a blinded manner by an independent statistician.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of General Surgery
Study Record Dates
First Submitted
April 2, 2022
First Posted
October 12, 2022
Study Start
July 1, 2025
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2033
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share